The Assesment of Pediatric Rehabilitation İnpatiens
PDF
Cite
Share
Request
Research
P: 55-59
March 2019

The Assesment of Pediatric Rehabilitation İnpatiens

Med J Bakirkoy 2019;15(1):55-59
1. Sağlık Bilimleri Üniversitesi İstanbul Fizik Tedavi Rehabilitasyon Eğitim ve Araştırma Hastanesi, Fiziksel Tıp ve Rehabilitasyon Kliniği, İstanbul, Türkiye
No information available.
No information available
Received Date: 04.03.2018
Accepted Date: 14.03.2018
PDF
Cite
Share
Request

ABSTRACT

Objective:

The aim of this study was to determine the frequency, clinical and demographic characteristics of inpatients in pediatric rehabilitation services.

Methods:

One hundred and fifty-three inpatients were evaluated. The gender, age, type of disease, etiology, orthoses, deformities, duration of hospitalization were recorded.

Results:

The mean age of one hundred and fifty-three patients (92 male, 61 female) was 5.5±3.7 years. The most commonly seen disorder was cerebral palsy with a 66.7% percentage. Spina bifida was noted as the second most common disease (8.5%). While the most common etiologic causes were prematurity in the prenatal period (45.8%), convulsion (36.6%) and trauma (10%) in the postnatal period. 81% of the patients had a foot deformity and 39.9% of them were using an Ankle Foot Orthosis (AFO). The other deformities and frequencies were noted as 57.5% knee deformity, 49% hip deformity, 23% upper extremity deformity and 11.8% axial deformities. 19% of the patients have had an operative procedure. Mean hospital stay duration was 36.3±3.7 months.

Conclusion:

The majority of patients in the pediatric rehabilitation service were patients with cerebral palsy, while one third were patients with other neurodevelopmental disorders. This study is important to determine the diseases of inpatients and to be aware of the existing deformities and orthoses.

Keywords:
Pediatrics, rehabilitation, cerebral palsy

References

1
Olney SJ, Wright MJ. Cerebral palsy. In: Campbell SK, Vander Linden DW, Palisano RJ, (eds). Physical therapy for children. 2nd edition, Philadelphia, W. B. Saunders, 2000, p. 533-571.
2
Helders PJ, Engelbert RH, Custers JW, Gorter JW, Takken T, van der Net J. Creating and being created: the chang- ing panorama of paediatric rehabilitation. Pediatr Rehabil 2003; 6:5-12.
3
Cusick A, McIntyre S, Novak I, Lannin N, Lowe K. A comparison of goal attainment scaling and the Canadian Occupational Performance Measure for paediatric rehabilitation research. Pediatr Rehabil 2006; 9:149-157.
4
 
5
Pharoah PO, Cooke T, Rosenbloom I. Trends in birth prevalence of cerebral palsy. Arch Dis Child. 1987; 62: 379-384.
6
Livingston MH, Rosenbaum PL, Russell DJ, et al. Quality of life among adolescents with cerebral palsy: what does the, litaerature tell us? Dev Med Child Neurol. 2007; 49:225-231.
7
Piccininni M, Falsini C, Pizzi A. Quality of life in hereditary neuromuscular diseases. Acta Neurol Scand 2004; 109:113-119
8
Koman LA, Smith BP, Shilt JS. Cerebral palsy. Lancet 2004; 363:1619-1631.
9
Bax M, Goldstein M, Rosenbaum P. Proposed definition and classification of cerebral palsy. Dev Med Child Neurol 2005; 47:571-576
10
Odding, E, Roebroeck ME, Stam HJ. The epidemiology of cerebral palsy: incidence, impairments and risk factors. Disability and rehabilitation, 2006; 28.4:183-191.
11
Nelson KB, Grether JK. Causes of cerebral palsy. Curr Opin Pediatr 1999; 11: 487-491.
12
Serdaroğlu A, Cansu A, Ozkan S, Tezcan S. Prevalence of cerebral palsy in Turkish children between the ages of 2 and 16 years. Dev Med Child Neurol 2006; 48:413-416.
13
Russman BS. Cerebral palsy: definition, manifestations and etiology. Türk Fiz Tıp Rehab Derg 2002;48:4-6.
14
Shutleff DB, Graaf WD. Overview of clinical issues in the management of myelomeningocele. Caring for the child with spina bifida, 1st edition. American Academy of Orthopedic Surgeons, Illinois, 2001.
15
Aydınlı K, Çağdaş A, Kayserili H, Tukel T, Eriş H, ApakMY. The effect of preconceptional folic acid treatmenton the recurrence risk of nonsyndromic neural tubedefects. Br J Med Genet 1998; 1: 120-124
16
Tunçbilek E. Türkiye’deki yüksek nöral tüp defekti sıklığı ve önlemek için yapılabilecekler. Çocuk sağlığı ve hastalıkları dergisi, 2004; 47.2:79-84.
17
Voit T. Congenital muscular dystrophies. Brain and Development 1998;20.2: 65-74.
18
Korf BR, Darras BT, Urion DK. Dystrophinopathies. GeneReviews: medical genetics knowledge base [online]. Update March, 24. 2004.
19
Billard C, Gillet P, Barthez M, Hommet C, Bertrand P. Reading ability and processing in Duchenne muscular dystrophy and spinal muscular atrophy. Dev Med Child Neurol 1998; 40: 12-20.
20
Şahin S, Doğan Ş, Aksoy K. Çocukluk çağı kafa travmaları. Uludag medical jorunal 2002; 28: 45-51.